Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Emily Viehl, PharmD, BCOP

Articles by Emily Viehl, PharmD, BCOP

Teclistamab-cqyv Shows Promise in Relapsed/Refractory Multiple Myeloma Following 4 Prior Lines of Therapy

ByEmily Viehl, PharmD, BCOP

February 16th 2023

Because of CRS and neurologic toxicity risk, the therapy is available through a REMS program.

Latest Updated Articles

$Teclistamab-cqyv Shows Promise in Relapsed/Refractory Multiple Myeloma Following 4 Prior Lines of Therapy$
Teclistamab-cqyv Shows Promise in Relapsed/Refractory Multiple Myeloma Following 4 Prior Lines of Therapy
Published: February 16th 2023 | Updated:

Trending on Pharmacy Times

Breaking News: CVS Buys Rite Aid, Bartell Drugs

FDA Approves 1-Minute HIV Self-Test

Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer

Young Women With Symptomatic Long COVID At Higher Risk of POTS

Kellermensch: Living With the Emotional Weight of a Career in Health Care

© 2025 MJH Life Sciences^®

All rights reserved.